← Back
$TARS All transactions

Tarsus Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$34K

Shares

493

Price

$70

Filed

Mar 18

Insider

Name

LINK WILLIAM J PHD

Title

CIK

0001228684

Roles

Director

Transaction Details

Transaction Date

2026-03-16

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

116,332

Footnotes

The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025. | The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $67.60 to $68.59. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $68.64 to $69.63. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $69.68 to $69.85. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001228684-26-000002

Form Type

4

Issuer CIK

0001819790

LINK WILLIAM J PHD's History

Date Ticker Type Value
2026-03-16 TARS $247K
2026-03-16 TARS $578K
2026-03-16 TARS $34K
2025-12-15 TARS $408K
2025-12-15 TARS $516K
2025-12-15 TARS $95K
2025-12-15 TARS $458K
2025-12-15 TARS $388K
2025-09-16 TARS G $0
2025-09-08 TARS $1.5M

Other Insiders at TARS (90d)

Insider Bought Sold Last
PYOTT DAVID E I 2026-02-18
LINK WILLIAM J PHD $825K 2026-03-16
Farrow Jeffrey S
See Remarks
$440K 2026-03-19
Mottiwala Aziz
Chief Commercial Officer
$893K 2026-03-19
Neervannan Seshadri
Chief Operating Officer
$1.6M 2026-03-20
Azamian Bobak R.
President/CEO and Board Chair
$2.4M 2026-03-19
Whitfield Dianne C.
Chief Human Resources Officer
$839K 2026-03-19
Wahl Bryan
General Counsel
$850K 2026-03-19
Lin Elizabeth Yeu
Chief Medical Officer
$78K 2026-03-19